Frontiers in Immunology (Dec 2023)
Multivariate analysis of FcR-mediated NK cell functions identifies unique clustering among humans and rhesus macaques
- Marina Tuyishime,
- Rachel L. Spreng,
- Rachel L. Spreng,
- Brady Hueber,
- Junsuke Nohara,
- Derrick Goodman,
- Derrick Goodman,
- Cliburn Chan,
- Cliburn Chan,
- Richard Barfield,
- Richard Barfield,
- Whitney E. Beck,
- Shalini Jha,
- Stephanie Asdell,
- Kevin Wiehe,
- Kevin Wiehe,
- Max M. He,
- David Easterhoff,
- Haleigh E. Conley,
- Taylor Hoxie,
- Thaddeus Gurley,
- Caroline Jones,
- Nihar Deb Adhikary,
- Francois Villinger,
- Rasmi Thomas,
- Thomas N. Denny,
- Thomas N. Denny,
- Michael Anthony Moody,
- Michael Anthony Moody,
- Michael Anthony Moody,
- Georgia D. Tomaras,
- Georgia D. Tomaras,
- Georgia D. Tomaras,
- Georgia D. Tomaras,
- Georgia D. Tomaras,
- Justin Pollara,
- Justin Pollara,
- Justin Pollara,
- R. Keith Reeves,
- R. Keith Reeves,
- R. Keith Reeves,
- Guido Ferrari,
- Guido Ferrari,
- Guido Ferrari
Affiliations
- Marina Tuyishime
- Department of Surgery, Duke University, Durham, NC, United States
- Rachel L. Spreng
- Duke Human Vaccine Institute, Durham, NC, United States
- Rachel L. Spreng
- Center for Human Systems Immunology, Durham, NC, United States
- Brady Hueber
- Center for Human Systems Immunology, Durham, NC, United States
- Junsuke Nohara
- Department of Surgery, Duke University, Durham, NC, United States
- Derrick Goodman
- Department of Surgery, Duke University, Durham, NC, United States
- Derrick Goodman
- Center for Human Systems Immunology, Durham, NC, United States
- Cliburn Chan
- Center for Human Systems Immunology, Durham, NC, United States
- Cliburn Chan
- Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, United States
- Richard Barfield
- Center for Human Systems Immunology, Durham, NC, United States
- Richard Barfield
- Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, United States
- Whitney E. Beck
- Department of Surgery, Duke University, Durham, NC, United States
- Shalini Jha
- Department of Surgery, Duke University, Durham, NC, United States
- Stephanie Asdell
- Department of Surgery, Duke University, Durham, NC, United States
- Kevin Wiehe
- Duke Human Vaccine Institute, Durham, NC, United States
- Kevin Wiehe
- Department of Medicine, Duke University, Durham, NC, United States
- Max M. He
- Duke Human Vaccine Institute, Durham, NC, United States
- David Easterhoff
- Duke Human Vaccine Institute, Durham, NC, United States
- Haleigh E. Conley
- Duke Human Vaccine Institute, Durham, NC, United States
- Taylor Hoxie
- Duke Human Vaccine Institute, Durham, NC, United States
- Thaddeus Gurley
- Duke Human Vaccine Institute, Durham, NC, United States
- Caroline Jones
- Duke Human Vaccine Institute, Durham, NC, United States
- Nihar Deb Adhikary
- New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, United States
- Francois Villinger
- New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, United States
- Rasmi Thomas
- U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States
- Thomas N. Denny
- Duke Human Vaccine Institute, Durham, NC, United States
- Thomas N. Denny
- Department of Medicine, Duke University, Durham, NC, United States
- Michael Anthony Moody
- Duke Human Vaccine Institute, Durham, NC, United States
- Michael Anthony Moody
- Department of Pediatrics, Duke University, Durham, NC, United States
- Michael Anthony Moody
- Department of Integrative Immunobiology, Duke University, Durham, NC, United States
- Georgia D. Tomaras
- Department of Surgery, Duke University, Durham, NC, United States
- Georgia D. Tomaras
- Duke Human Vaccine Institute, Durham, NC, United States
- Georgia D. Tomaras
- Center for Human Systems Immunology, Durham, NC, United States
- Georgia D. Tomaras
- Department of Integrative Immunobiology, Duke University, Durham, NC, United States
- Georgia D. Tomaras
- 0Department of Molecular Genetics and Microbiology, Duke University, Durham, NC, United States
- Justin Pollara
- Department of Surgery, Duke University, Durham, NC, United States
- Justin Pollara
- Duke Human Vaccine Institute, Durham, NC, United States
- Justin Pollara
- Center for Human Systems Immunology, Durham, NC, United States
- R. Keith Reeves
- Department of Surgery, Duke University, Durham, NC, United States
- R. Keith Reeves
- Center for Human Systems Immunology, Durham, NC, United States
- R. Keith Reeves
- 1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States
- Guido Ferrari
- Department of Surgery, Duke University, Durham, NC, United States
- Guido Ferrari
- Duke Human Vaccine Institute, Durham, NC, United States
- Guido Ferrari
- Center for Human Systems Immunology, Durham, NC, United States
- DOI
- https://doi.org/10.3389/fimmu.2023.1260377
- Journal volume & issue
-
Vol. 14
Abstract
Rhesus macaques (RMs) are a common pre-clinical model used to test HIV vaccine efficacy and passive immunization strategies. Yet, it remains unclear to what extent the Fc-Fc receptor (FcR) interactions impacting antiviral activities of antibodies in RMs recapitulate those in humans. Here, we evaluated the FcR-related functionality of natural killer cells (NKs) from peripheral blood of uninfected humans and RMs to identify intra- and inter-species variation. NKs were screened for FcγRIIIa (human) and FcγRIII (RM) genotypes (FcγRIII(a)), receptor signaling, and antibody-dependent cellular cytotoxicity (ADCC), the latter mediated by a cocktail of monoclonal IgG1 antibodies with human or RM Fc. FcγRIII(a) genetic polymorphisms alone did not explain differences in NK effector functionality in either species cohort. Using the same parameters, hierarchical clustering separated each species into two clusters. Importantly, in principal components analyses, ADCC magnitude, NK contribution to ADCC, FcγRIII(a) cell-surface expression, and frequency of phosphorylated CD3ζ NK cells all contributed similarly to the first principal component within each species, demonstrating the importance of measuring multiple facets of NK cell function. Although ADCC potency was similar between species, we detected significant differences in frequencies of NK cells and pCD3ζ+ cells, level of cell-surface FcγRIII(a) expression, and NK-mediated ADCC (P<0.001), indicating that a combination of Fc-FcR parameters contribute to overall inter-species functional differences. These data strongly support the importance of multi-parameter analyses of Fc-FcR NK-mediated functions when evaluating efficacy of passive and active immunizations in pre- and clinical trials and identifying correlates of protection. The results also suggest that pre-screening animals for multiple FcR-mediated NK function would ensure even distribution of animals among treatment groups in future preclinical trials.
Keywords